The End of Statin Nation? For decades, patients and doctors have accepted daily pills as the norm for managing low density lipoprotein cholesterol (LDL C), also known as "bad" cholesterol.
However, recent trials in the US and China suggest that a new era may be on the horizon, where a single shot could potentially control bad cholesterol forever.
The breakthrough lies in CRISPR gene editing, which has revolutionized our understanding of genetics.